Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 103.90-50.38-3.8346.34-8.99

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 103.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34
Mar2020-8.99

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34
Positive
Mar2020 -8.99 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹2,062.9 Cr -3.9% -7.2% 109.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-3.9%

-7.2%

109.4%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses